Cyproheptadine Hydrochloride Tablet
Product Images NDC 50268-201

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyproheptadine Hydrochloride (NDC 50268-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (201 15)

Packaging label for Cyproheptadine Hydrochloride Tablets USP, 4 mg, oral tablets, containing 50 tablets (5 x 10 unit dose). The label indicates prescription use only and includes storage instructions, manufacturer AvPAK, and a barcode. The product NDC is 50268-201-15.*

FDA Label Image

Chemical Structure (Cyproheptadine Hydrochloride Tablets 1)

Chemical structure of Cyproheptadine Hydrochloride depicting molecular rings and bonds, including a hexagonal ring with nitrogen and methyl group, alongside the hydrochloride component (HCl).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.